Arrhythmogenic right ventricular dysplasia (ARVD), also known as arrhythmogenic right ventricular cardiomyopathy (ARVC), is a leading cause of sudden death among young athletes. But it can affect people of all ages and all activity levels.
At the Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia (Cardiomyopathy) Program, we are committed to finding a cure for ARVD (ARVC). We help patients and their families with screening, education and advanced medical and surgical treatments.
Our team of experts is dedicated to ARVD (ARVC) patients and their families. Meet the team.
Are you seeking treatment for ARVD (ARVC)? Contact us.
ARVD (ARVC) patients and families can participate in our research. Find a program.